Thermo Fisher Scientific Sees $1.6M Bullish Call Sweep as Stock Holds Near Midpoint of 52-Week Range

By TrendSpider Editor

Unusual options activity surfaced in Thermo Fisher Scientific Inc (TMO) on Monday, with a notable $1,605,000 call contract flagging at the $530 strike, pointing to potential bullish positioning ahead of the December expiration. TMO shares are trading at $528.75, up 0.33% on the session, and sit in t

Thermo Fisher Scientific Sees $1.6M Bullish Call Sweep as Stock Holds Near Midpoint of 52-Week Range

Unusual options activity surfaced in Thermo Fisher Scientific Inc (TMO) on Monday, with a notable $1,605,000 call contract flagging at the $530 strike, pointing to potential bullish positioning ahead of the December expiration. TMO shares are trading at $528.75, up 0.33% on the session, and sit in the middle of their 52-week range of $403.36 to $643.99. The options flow arrives at a technically significant moment, with the stock hovering just below the call strike and leaving traders to determine whether the move signals a breakout attempt or a hedge against an existing short position.

Key Drivers of the TMO Stock Move

• Main Catalyst: Two unusual options contracts were flagged today totaling $1,633,452 in combined premium. The dominant trade is a call at the $530 strike expiring December 18, 2026, with a size of 300 contracts and an open interest ratio of 303%, meaning volume dramatically exceeded existing open interest. A smaller put contract at the $500 strike expiring August 28, 2026 carried a size of just 20 contracts but registered an open interest ratio of 2,000%, making it statistically extreme relative to its existing open interest baseline.
• Bull Case: The $1,605,000 call sweep is in-the-money relative to the current price of $528.75, with the $530 strike sitting just $1.25 above the market. The December 2026 expiration gives the trade roughly five months of runway, suggesting the buyer is not making a short-term directional gamble but is instead expressing a longer-term conviction that TMO can sustain a move above $530 and potentially challenge higher levels within the 52-week range that extends up to $643.99.
• Bear Case: The put contract at $500 striking August 28, 2026, while small in absolute premium at $28,452, carries a 2,000% open interest ratio, which is the more statistically extreme of the two signals. That level of relative volume on an out-of-the-money put suggests someone is making a pointed near-term downside bet, with a target roughly 5.4% below the current price of $528.75. If TMO fails to hold above $500 over the next six weeks, the bearish read gains credibility.

The forward setup for TMO is defined by its positioning within a wide 52-week range. The stock has recovered meaningfully from its 52-week low of $403.36 but remains well below its high of $643.99, leaving significant room in both directions. The December call trade implies a bullish bias with a multi-month time horizon, while the August put introduces a short-term counterpoint worth monitoring. The divergence between the two contracts, one long-dated and bullish, one near-term and bearish, reflects genuine uncertainty in the market about whether TMO's current price level represents a launching pad or a ceiling.

TMO Unusual Options Activity

• Contract 1: Call | Strike: $530 | Expiry: December 18, 2026 | Volume: 300 | Open Interest Ratio: 303% | Status: In-the-Money
• Contract 2: Put | Strike: $500 | Expiry: August 28, 2026 | Volume: 20 | Open Interest Ratio: 2,000% | Status: Out-of-the-Money

Total unusual premium flagged across both contracts came to $1,633,452, with calls accounting for the overwhelming majority at $1,605,000. The call-to-put skew in premium terms is strongly tilted bullish, though the put's extraordinary open interest ratio of 2,000% keeps the bearish signal on the radar for traders watching near-term price action through late August.

TMO Seasonality

Mid-July has historically been an active period for large-cap healthcare and life sciences names as the market positions ahead of second-quarter earnings season. With the December call expiration in play, the options buyer has positioned to capture any post-earnings momentum that could carry through the back half of 2026.

TMO Relative Performance

TMO's 0.33% gain on the session is modest but constructive, reflecting steady demand at current levels. At $528.75, the stock trades roughly 31% above its 52-week low of $403.36 but remains approximately 18% below its 52-week high of $643.99, indicating that while the recovery from the lows has been substantial, there is meaningful technical work still to be done before TMO can challenge its prior highs.